rss
BMJ Case Reports 2017; doi:10.1136/bcr-2017-222006
  • Rare disease
  • CASE REPORT

Abrikossoff’s tumour on the upper limb: a rare presentation

  1. Miguel Nico Albano
  1. Department of Surgery C (Covões), Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Portugal
  1. Correspondence to Dr Carlos E Costa Almeida, carloscostaalmeida{at}yahoo.com
  • Accepted 30 October 2017
  • Published 9 November 2017

Summary

Abrikossoff’s tumour or granular cell tumour is a rare entity. Most common locations are the head and neck, with only a few cases reported on the upper limbs. A 55-year-old man with a nodular lesion on the left arm resorted to surgery consultation. Nodule was firm, mobile, painless and non-ulcerated. Total excision using a Limberg flap procedure was performed. Following 3 months of follow-up, the patient is fine. Abrikossoff’s tumour is frequently presented in the second to sixth decade of life as an ulcerated nodule with progressive growth. Malignant form is rare, with metastases occurring in up to 3% of patients. Excision must be accomplished with free margins. Recurrence is rare. Abrikossoff’s tumour on the upper limbs is rare. Although benignity is the rule, doctors must be aware of the possibility of harbouring a cancer. Surgery is the treatment of choice.

Footnotes

  • Contributors CCA: study design, data collection, manuscript writing, manuscript review. MNA: data collection, manuscript review. TC: manuscript writing, review. MS: manuscript review.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article